These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 11718438)
1. Cox-2 inhibitors and cardiovascular risk: we defend our data and suggest caution. Mukherjee D; Nissen SE; Topol EJ Cleve Clin J Med; 2001 Nov; 68(11):963-4. PubMed ID: 11718438 [No Abstract] [Full Text] [Related]
2. Cox-2 inhibitors and cardiovascular risk: the data are inconclusive, and these drugs are needed. Lipani J Cleve Clin J Med; 2001 Nov; 68(11):961-2. PubMed ID: 11718437 [No Abstract] [Full Text] [Related]
3. Cox-2 inhibitors and cardiovascular risk: point and counterpoint. Mandell BF Cleve Clin J Med; 2001 Nov; 68(11):957-60. PubMed ID: 11718436 [No Abstract] [Full Text] [Related]
8. [New study of selective COX-2 inhibitors. Protecting the stomach while risking the heart? (interview by Dr. Beate Schumacher)]. Zeidler H MMW Fortschr Med; 2001 Sep; 143(35-36):14. PubMed ID: 11584521 [No Abstract] [Full Text] [Related]
9. Biomedicine. Back to an aspirin a day? Vane JR Science; 2002 Apr; 296(5567):474-5. PubMed ID: 11964462 [No Abstract] [Full Text] [Related]
10. COX 2 inhibitors may increase risk of heart attack. Gottlieb S BMJ; 2001 Sep; 323(7311):471. PubMed ID: 11532833 [No Abstract] [Full Text] [Related]
11. Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events. Mukherjee D Biochem Pharmacol; 2002 Mar; 63(5):817-21. PubMed ID: 11911832 [TBL] [Abstract][Full Text] [Related]
14. The risk for myocardial infarction with cyclooxygenase-2 inhibitors. Kim JA; Choi YS; Yoon D; Cho KH Ann Intern Med; 2005 Oct; 143(8):615-6; author reply 617-8. PubMed ID: 16230734 [No Abstract] [Full Text] [Related]
15. COX-2 inhibitors: balancing the hope, the hype, and the concern. Mandell BF Cleve Clin J Med; 2001 Nov; 68(11):899. PubMed ID: 11718429 [No Abstract] [Full Text] [Related]
16. The risk for myocardial infarction with cyclooxygenase-2 inhibitors. Shinmura K; Bolli R Ann Intern Med; 2005 Oct; 143(8):617; author reply 617-8. PubMed ID: 16230737 [No Abstract] [Full Text] [Related]
17. The risk for myocardial infarction with cyclooxygenase-2 inhibitors. Pijak MR; Huzicka I; Gazdik F Ann Intern Med; 2005 Oct; 143(8):616-7; author reply 617-8. PubMed ID: 16230736 [No Abstract] [Full Text] [Related]
18. Cyclooxygenase inhibition: between the devil and the deep blue sea. Hawkey CJ Gut; 2002 May; 50 Suppl 3(Suppl 3):III25-30. PubMed ID: 11953329 [TBL] [Abstract][Full Text] [Related]
19. [COX-2 specific inhibitors are similar--and different]. Aly A Lakartidningen; 2000 Sep; 97(38):4181-2. PubMed ID: 11068393 [No Abstract] [Full Text] [Related]